# 1315 Capital: portfolio, investments and team > 1315 Capital is a private equity based in United States. 1 investment on record, latest Oct 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/1315-capital (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # 1315 Capital Filed with the SEC to raise a fund in Mar 2026, closing $21M. Last cheque observed Oct 2015. Email Private equity Quiet New fund $21M, Mar 2026 Series A Series B Growth Longevity E-health Molecules Follow 1315 Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2F1315-capital) Cheques on record **0%** of best year **0** **cheques in 12 months**, 1 on record Since the last cheque **4050** days **00** hrs **00** min **00** sec Rounds led **0 of 1** Sole investor **1 rounds** Pitch 1315 Capital ## 1315 Capital highlights - 01 1 rounds on record - 02 Mostly Series A: 100% of its rounds - 03 Sole investor in 1 rounds, median undisclosed ## What they do > 1315 Capital invests in commercial-stage healthcare companies across healthcare services, pharma/medtech products, pharma/medtech outsourcing, and health & wellness companies. From their own website - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Series A Series B Growth - **Sectors:** Longevity E-health Molecules - **Based in:** Philadelphia, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **1 appearances** - **2015** 1 round - **Oct** **[Onkos Surgical](https://millionrounds.com/company/onkos-surgical)** Series A **Undisclosed** Sole investor An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **4 named** AC **Adele Cirone Oliva** Sole Member of (i) the General Partner of the General Partner and (ii) the General Partner of the Managing Member of the Investment Manager i Filing they signed BR **Brian Richard Schwenk** Chief Financial Officer of the Investment Manager i Filing they signed MM **M Michael Koby** Partner i Form ADV MC **Michael C Koby** Member of the General Partner and the Investment Manager i Filing they signed We also hold **31** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$1.4B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** 1315 Capital, LLC - **SEC number:** CRD 175292 Funds on its Form ADV **8** private funds, **$1.1B** in gross assets · filed Mar 2024 - 1315 Capital, L.P. *Private equity* 70 investors $295M - 1315 Capital II, L.P. *Private equity* 77 investors $282M - 1315 Capital III, L.P. *Private equity* 60 investors $267M - 1315 Capital Emerging Growth & Buyout, L.P. *Private equity* 59 investors $119M - 1315 Capital III Parallel, L.P. *Private equity* 41 investors $113M - 1315 Capital Emerging Growth & Buyout Parallel, L.P. *Private equity* 36 investors $56M - 1315 Capital AIV II, L.P. *Private equity* 36 investors $3.0M - 1315 Capital AIV, L.P. *Private equity* 19 investors $843K ## What they claim to have backed From their own portfolio page (on their website) **1** of 2 we have independently watched raise [Ajust](https://millionrounds.com/company/ajust) Cookiedatabase Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. New fund on file **$21M** raised in Mar 2026 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Series A Series B Growth Median round joined **-** the round, not its cheque Alone, median **-** Led 0 of 1 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Oct 2015 Rounds by stage said on their site - Series A said *1* - Series B said *-* - Growth said *-* **Pitching 1315 Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Quick answers about 1315 Capital ### What does 1315 Capital invest in? 1315 Capital invests most often at Series A (100% of the rounds on record), in sectors such as Longevity, E-health and Molecules. ### How active is 1315 Capital? 1 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2015. ### Is 1315 Capital investing now? No investments in the last 12 months; the latest was in Oct 2015. ### What kind of investor is 1315 Capital? 1315 Capital is a private equity firm based in Philadelphia, United States. ### How much does 1315 Capital manage? About $1.4B, as regulatory assets under management (Oct 2026). ### Has 1315 Capital raised a new fund? Its latest fund filing with the SEC was in Mar 2026, reporting $21M raised. ### When was 1315 Capital founded? 1315 Capital was founded in 2014. ### Where does this information on 1315 Capital come from? From public registers and its own website, checked and rebuilt every night. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=1315-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=1315-capital)